Combined Resection Liver Metastases and Peritoneal Metastases

2017 ◽  
pp. 161-179
Author(s):  
Arie Ariche ◽  
Dan Aderka ◽  
Almog Ben-Yaacov ◽  
Aviram Nissan
Keyword(s):  
Liver Metastases ◽  
Peritoneal Metastases ◽  
Combined Resection

scholarly journals Laparoscopic combined resection of liver metastases and colorectal cancer: a multicenter, case-matched study using propensity scores

2018 ◽  
Vol 33 (4) ◽  
pp. 1124-1130 ◽  
Author(s):  
M. J. van der Poel ◽  
P. J. Tanis ◽  
H. A. Marsman ◽  
A. M. Rijken ◽  
E. C. Gertsen ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Liver Metastases ◽  
Propensity Scores ◽  
Combined Resection ◽  
Matched Study

scholarly journals Diagnostic Laparoscopy with Ultrasound Still Has a Role in the Staging of Pancreatic Cancer: A Systematic Review of the Literature

HPB Surgery ◽  
2016 ◽  
Vol 2016 ◽  
pp. 1-8 ◽  
Author(s):  
Jordan Levy ◽  
Mehdi Tahiri ◽  
Tsafrir Vanounou ◽  
Geva Maimon ◽  
Simon Bergman
Keyword(s):  
Pancreatic Cancer ◽  
Liver Metastases ◽  
Prospective Studies ◽  
Diagnostic Laparoscopy ◽  
Preoperative Staging ◽  
Peritoneal Metastases ◽  
Pancreatic Tumors ◽  
Vascular Involvement ◽  
Morbidity Rate ◽  
Year 2000

Background. The reported incidence of noncurative laparotomies for pancreatic cancer using standard imaging (SI) techniques for staging remains high. The objectives of this study are to determine the diagnostic accuracy of diagnostic laparoscopy with ultrasound (DLUS) in assessing resectability of pancreatic tumors. Study Design. We systematically searched the literature for prospective studies investigating the accuracy of DLUS in determining resectability of pancreatic tumors. Results. 104 studies were initially identified and 19 prospective studies (1,573 patients) were included. DLUS correctly predicted resectability in 79% compared to 55% for SI. DLUS prevented noncurative laparotomies in 33%. Of those, the most frequent DLUS findings precluding resection were liver metastases, vascular involvement, and peritoneal metastases. DLUS had a morbidity rate of 0.8% with no mortalities. DLUS remained superior to SI when analyzing studies published only in the last five years (100% versus 81%), enrolling patients after the year 2000 (74% versus 58%), or comparing DLUS to modern multidimensional CT (100% versus 78%). Conclusion. DLUS seems to still have a role in the preoperative staging of pancreatic cancer. With its ability to detect liver metastases, vascular involvement, and peritoneal metastases, the use of DLUS leads to less noncurative laparotomies.

scholarly journals Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases

2004 ◽  
Vol 239 (6) ◽  
pp. 818-827 ◽  
Author(s):  
Eddie K. Abdalla ◽  
Jean-Nicolas Vauthey ◽  
Lee M. Ellis ◽  
Vickie Ellis ◽  
Raphael Pollock ◽  
...  
Keyword(s):  
Radiofrequency Ablation ◽  
Liver Metastases ◽  
Hepatic Resection ◽  
Colorectal Liver Metastases ◽  
Combined Resection

Patterns of gastric cancer metastasis within the United States.

2020 ◽  
Vol 38 (4_suppl) ◽  
pp. 329-329
Author(s):  
Joseph Sirody ◽  
Amy H. Kaji ◽  
Danielle M. Hari ◽  
Kathryn Tzung-Kai Chen
Keyword(s):  
United States ◽  
Gastric Cancer ◽  
Overall Survival ◽  
Liver Metastases ◽  
Cancer Metastasis ◽  
The United States ◽  
Peritoneal Metastases ◽  
Peritoneal Disease ◽  
Metastatic Site ◽  
Signet Ring

329 Background: There are few reports on the epidemiology of gastric cancer metastasis, although outcomes are known to be uniformly poor. Here we describe the patterns of gastric cancer metastasis and treatment in the United States (US). Methods: Patients with gastric adenocarcinoma histologies were identified in the National Cancer Database (NCDB) from 2004-2016. We describe univariate associations between different sites of metastasis and clinicopathologic characteristics and treatment modalities, using the chi-square and Kruskal-Wallis tests. Kaplan Meier curves were constructed for the estimation of overall survival (OS) by metastatic site. Results: Due to changes in the coding of metastatic disease, we were limited to the year 2016 for evaluation of patterns of disease. Twenty-six percent (n = 1228) of gastric cancer patients presented with liver metastases, 20% (n = 941) with distant nodes, 43% (n = 2028) with other distant site metastases (including peritoneum), and the rest to bone, brain or lung. On univariate analysis, when compared to liver metastases, other distant site metastases were significantly more likely to arise from an antral primary site (28% v. 16%); to be of Hispanic origin (16% v. 7%); female (42% v. 29%); associated with signet ring histology (34% v. 6%); lymphovascular invasion (LVI) (58% v. 27%); and tumor grade III/IV (85% vs. 60%) (p < 0.0001 for all). There were no significant differences in how patients with metastatic disease were treated in terms of systemic therapy. With regard to OS, due to how metastatic sites were coded prior to 2016, it was not possible to compare peritoneal metastases against other sites; however, patients with distant nodal disease had improved median overall survival compared to those with any other metastatic site (7.9 v. 5.2 months, p < 0.0001). Conclusions: The majority of US patients with metastatic gastric cancer present with presumed peritoneal disease. Predictive factors for peritoneal metastases vs. liver metastases included adverse prognostic features, including signet ring histology, higher tumor grades, and LVI. Although it was not possible to compare OS of peritoneal disease against other sites, continued follow up is needed, as this may impact future staging.

Combined Resection And Radiofrequency Ablation For Bilobar Liver Metastases

2008 ◽  
Vol 34 (10) ◽  
pp. 1168
Author(s):  
Elaine Y.L. Leung ◽  
C. Roxburgh ◽  
E. Leen ◽  
P. Horgan
Keyword(s):  
Radiofrequency Ablation ◽  
Liver Metastases ◽  
Combined Resection
Sign in / Sign up

Export Citation Format

Share Document